CDEK
← Mechanisms of action

Lewis Y antigen

OLIGOSACCHARIDEHomo sapiens

Drugs acting on this target (22)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
b3(fv)-pe38Binding agentexperimentalmAbLewis Y antigen binding agent
cmd-193Binding agentexperimentalmAbLewis Y antigen binding agent
hu3s193Binding agentexperimentalmAbLewis Y antigen binding agent
ign312Binding agentexperimentalmAbLewis Y antigen binding agent
lmb-1Binding agentexperimentalmAbLewis Y antigen binding agent
lmb-9Binding agentexperimentalmAbLewis Y antigen binding agent
sgn-15Binding agentexperimentalmAbLewis Y antigen binding agent
b3(fv)-pe38Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
cmd-193Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
gnx102Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
hu3s193Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
ign312Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
in111 monoclonal antibody hu3s193Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
lmb-1Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
lmb-9Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
mvt-1075Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
mvt-2163Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
mvt-5873Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
sgn-15Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
tils and car-tils targeting her2, mesothelin, psca, muc1, lewis-y, gpc3, axl, egfr, claudin18.2/6, ror1, gd1, or b7-h3Immunity, passiveexperimentalCell therapyLewis Y antigen immunity, passive
y90 monoclonal antibody b3Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive
y90 monoclonal antibody hu3s193Immunity, passiveexperimentalmAbLewis Y antigen immunity, passive